Articles On Imugene (ASX:IMU)

Highlights Imugene Limited (ASX:IMU) has received human research ethics approval for Phase I human trial of anti-cancer oncolytic virotherapy VAXINIA Tasman Oncology Research, a comprehensive cancer hospital in South Australia, is the...

Imugene (IMU) receives Human Research Ethics Committee (HREC) approval to commence a phase one clinical trial of its VAXINIA drug in Australia The approval confirms the company has completed all necessary pre-clinical safety and efficacy...

Miners lead shares higher; IGO-Tiangi to buy Essential Metals; Ian Wells to leave Fortescue; Core Lithium relocates; Collimate sale delayed and Imugene gets Vaxinia ethics nod.

The S&P/ASX 200 Index (ASX: XJO) wobbled in and out of the green this afternoon before ultimately closing the day higher. The index was up 0.06% at 7,063.6 points at the end of Thursday’s session. While many miners came in among the...

An early rally lost momentum following soft Chinese economic data and as negative US futures suggested investors were having second thoughts about a hawkish interest rate outlook from the Federal Reserve. The S&P/ASX 200 finished fou...

Australian stocks climbed to their highest in a week after Wall Street took in its stride confirmation interest rates are unlikely to fall this year. The S&P/ASX 200 rose as much as 40 points in early action before resetting to neutr...

The S&P/ASX 200 Index (ASX: XJO) recovered from Tuesday’s fall today, lifting 1.63% to close at 7,059.2 points. Its gains came despite a rough night’s trade on Wall Street. The Dow Jones Industrial Average Index (DJX: .DJI) traded...

Aussie shares climbed into positive territory for 2023 after reports of fresh support for China’s ailing economy helped the market reverse opening-day losses.   Banks, tech companies and gold miners led as the S&P/ASX 200 rallied 113...

The share market bounced off an eight-week low after Wall Street pared sharp initial losses during the US’s first session of 2023.   The S&P/ASX 200 climbed 90 points or 1.3 per cent towards its first gain of the year. The Australian...

Ending the year on a high note, the S&P/ASX 200 Index (ASX: XJO) rallied on the last trading day of 2022. The benchmark index climbed 0.26% to 7,038.7 points, following in the footsteps of the US stock market last night. Nearly all se...

Highlights The ASX 200 benchmark index closed in the green today (December 30), gaining 34.80 points or 0.50% to end at 7,054.90. The index lost 0.74% in the last five days and 6.10% over the last 52 weeks. IT sector emerged as the bi...

Aussie shares fell for a third session, pacing broad falls on Wall Street as markets priced in the risk of a US recession in 2023. The S&P/ASX 200 declined 82 points or 1.16 per cent by the halfway mark. The fall put the index on tra...

A whopping insider buy just went down with shares in technology-focused listed investment company (LIC) Thorney Technologies Ltd (ASX: TEK). Perhaps more excitingly, the purchase was made by a rich lister who boasts a billion-dollar fortun...

It can take a long time to bring a new drug to market, but companies that succeed reap mighty rewards. Any time a company is working in drug manufacturing and clinical research, the compound needs to be tested on human subjects to ensure...

The S&P/ASX 200 falls on first day of Christmas trading week, down 0.21% Nickel Industries (ASX:NIC), gold miners lead ASX large caps gainers Star Entertainment Group tumbles as CEO hits back at increases to casino tax in NSW   ‘Twas...

Highlights The ASX 200 benchmark index closed in the red today (December 19), losing 14.70 points or 0.21% to end at 7,134.00 points. Over the last five days, the index has lost 0.65% and 2.33% over the last 52 weeks. Materials was th...

Australian shares tracked falls on Wall Street after the Federal Reserve raised US interest rates and signalled more hikes next year. The S&P/ASX 200 declined 32 points or 0.44 per cent by mid-session. The market took in its stride u...

Local shares finished higher ahead of the Fed rates call tonight Energy and gold stocks led Binance sees massive withdrawals   Local shares joined Wall Street in the green, up by 0.60%, as traders await the Fed’s rates decision later toni...

The S&P/ASX 200 Index (ASX: XJO) traded in the green on Tuesday, recovering some of yesterday’s slump. At the end of today’s session, the index was 0.31% higher at 7,203.3 points Tech shares were among the market’s best performe...

The share market rose for only the second time in six sessions before halving its gains ahead of risk events in the US.   The S&P/ASX 200 slashed a 47-point opening rally to 22.5 points or 0.31 per cent by the close. Caution set in a...

Local shares finished slightly higher ahead of the FOMC meeting later tonight Sam Bankman-Fried arrested in the Bahamas CSL has a new CEO   Local shares dipped in the afternoon, finishing the day just 0.30% higher despite a strong start....

The S&P/ASX 200 Index (ASX: XJO) had another shocker today, notching up its third loss in a row for the week. The index finished up at 7,175.5 points, down 0.75% for the day. Since Monday, the ASX 200 has already lost a nasty 2%. These...

Energy stocks dragged ASX lower Core Lithium got a Sell rating from Goldman Sachs RBA says it’s still looking into a Central Bank Digital Currency (CBDC) in Australia   Energy stocks dragged local shares lower on Thursday as more talks of...

In morning trade, the Santos Ltd (ASX: STO) share price is edging lower. At the time of writing, the energy producer’s shares are down 0.7% to $7.20. While disappointing, this compares favourably to other energy shares which are falling he...

On Monday, the S&P/ASX 200 Index (ASX: XJO) started the week with a gain. The benchmark index rose 0.3% to 7,325.6 points. Will the market be able to build on this on Tuesday? Here are five things to watch: ASX 200 expected to fall T...

The S&P/ASX 200 Index (ASX: XJO) got off to a good start this week. The index finished Monday’s session 0.33% higher at 7,325.6 points. The S&P/ASX 200 Energy Index (ASX: XEJ) posted the market’s biggest gains today, lifting 1....

The BHP Group Ltd (ASX: BHP) share price has charged higher today. BHP shares are up 2.80% near the close, trading at $47.00 after hitting a high of $47.25 earlier this afternoon. The S&P/ASX 200 Index (ASX: XJO) is also in the gree...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a solid gain. At the time of writing, the benchmark index is up 0.5% to 7,340.4 points. Four ASX shares that are climbing more than most today a...

NSB files new patent in Australia Imugene doses first patient in Phase 1 trial Cronos and MGC Pharma give sales update   NSB announces patent filing in Australia NeuroScientific Biopharma (ASX:NSB) announced a new patent filing in Austral...

Highlights Australian shares opened flat on Wednesday. The ASX 200 rose marginally in opening trade, up 3.20 points, or 0.044%, to 7,256.50. On Tuesday, the benchmark index ended 0.3% higher at 7,253.3 points. Australi...

The S&P/ASX 200 Index (ASX: XJO) spent the afternoon in the green on Tuesday. The index closed today’s session 0.33% higher at 7,253.3 points. That was despite an early downturn that saw it dump as much as 0.39% to an intraday low of...

The ASX snapped a 4-day winning streak Energy stocks paced the bourse lower The RBA apologised over guidance   Energy paced the ASX lower on Monday as crude prices fell to the lowest level since December last year. At the close, the ASX 2...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

The Imugene Limited (ASX: IMU) share price has had a tough run lately. Imugene shares have dropped nearly 12% since market close on 15 November. The company’s share price was flat today and closed the day trading at 19 cents. Let’s ta...

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated. Even well into his 90s...

ShareCafeEnergy rallies on optimism surrounding China’s Zero-COVID policy: ASX closes 0.27% lower by Peter Milios   Energy, Material and Real Estate were the only sectors in the green in today’s day of trading. Energy was the best performer...

Highlights The ASX 200 benchmark index closed in the red today (November 16), losing 19.40 points or 0.27% to end at 7,122.20 points. Over the last five days, the index has gained 1.76%, but is down 4.33% for the last year to date. En...

The ASX 200 retreated on Wednesday IMF says the RBA needs to keep hiking rates Trump announced his 2024 presidential run   Local shares retreated 0.35% on Wednesday, dragged down by shares in Healthcare, Financials and Discretionary secto...

The S&P/ASX 200 Index (ASX: XJO) slipped on Tuesday as lithium stocks weighed on the market. The index closed 0.07% lower at 7,141.6 points. It followed a weak session on Wall Street overnight in which the Dow Jones Industrial Average...

ShareCafeASX falls after lithium stocks crumble: ASX closes 0.07% lower by Peter Milios   Sectors were mostly mixed today, and the S&P/ASX 200 was 0.07 per cent or 4.70 points lower at 7141.6 at the closing bell. Healthcare slightly edg...

Lithium stocks dragged down the ASX today Cannon-Brookes wins AGL board tussle at the AGM CBA reported Q1 results   The ASX 200 index finished marginally lower today, down 0.1%, as losses in lithium mining stocks were offset by gains in H...

Imugene (IMU) presents new data for its onCARlytics oncolytic virus at the Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in Boston, USThe company presented two different sets — the first for a treatment with fellow biotec...

The ASX dropped 0.5% on Thursday Origin Energy gets takeover offer, shares up 35% Key US inflation report scheduled tonight   Aussie shares fell 0.50% on Thursday as hopes of a quick Chinese recovery turn sour. Overnight, Wall St fell aro...

The ASX up 0.53% with 8 out of 11 sectors in the green Low Aussie dollar is lifting petrol prices which rose by 11.1 cents last week CBA says the world oil prices continues to be a key influence on global inflation   The ASX 200 finished...

Arovella Therapeutics (ALA) is set to receive a European patent for its iNKT cell therapy platform, under licence to the company from Imperial College InnovationsALA says the European Patent Office has issued it a notification of intent to...

The ASX up 0.54% with 6 out of 11 sectors in the green RBA raises forecasts for inflation, again, expects peak in mid-2023 CBA chief economist says need to closely watch statements from listed companies   After following in the footsteps...

The S&P/ASX 200 Index (ASX: XJO) finished the week on a strong note. It gained 0.5% on Friday to close at 6,892.5 points. That leaves it 1.57% higher than it was this time last week. The Aussie bourse was driven higher by the S&P/A...

The ASX 200 sank almost 2% on Thursday following the Fed’s 75bp hike last night All sectors except Comm Services were in the red Woolworths reported sluggish profit growth   Aussie shares sank almost 2% on Thursday as investors reacted to...

The S&P/ASX 200 Index (ASX: XJO) spent a third consecutive day in the green on Wednesday. The index gained 0.14% to close at 6,986.7 points. That marks its highest close in seven weeks. That’s despite a dire night on Wall Street. The...

Highlights The ASX 200 benchmark index closed up today (1 November), gaining 113.40 points or 1.65% to end at 6,976.90 points. Over the last five days, the index has gained 2.62%, but is down 6.28% for the last year to date. Materials...